Prognostic value of creatine kinase-myocardial band isoenzyme elevation following percutaneous coronary intervention: A meta-analysis

Catheterization and Cardiovascular Interventions

Volumn 81, Issue 6, 2013, Pages 959-967

  Jang, Jae Sik ^a   Jin, Han Young ^a   Seo, Jeong Sook ^a   Yang, Tae Hyun ^a   Kim, Dae Kyeong ^a   Kim, Dong Soo ^a   Cho, Kyoung Im ^b   Kim, Bo Hyun ^c   Je, Hyung Gon ^d   Park, Yong Hyun ^d  

^a Inje University College of Medicine   (South Korea)

^b Maryknoll Hospital   (South Korea)

^c Pusan National University School of Medicine   (South Korea)

^d Pusan National University Yangsan Hospital   (South Korea)

Author keywords

embolization; myocardial infarction; percutaneous coronary intervention

Indexed keywords

CREATINE KINASE; ISOENZYME; MYOCARDIAL BAND ISOENZYME; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DOSE RESPONSE; EFFECT SIZE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; PARAMETERS; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; UPPER LIMIT OF NORMAL;

AGED; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CREATINE KINASE, MB FORM; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; NECROSIS; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 84876497137     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24542     Document Type: Article

References (34)

1. Califf RM, Abdelmeguid AE, Kuntz RE, Popma JJ, Davidson CJ, Cohen EA, Kleiman NS, Mahaffey KW, Topol EJ, Pepine CJ, Lipicky RJ, Granger CB, Harrington RA, Tardiff BE, Crenshaw BS, Bauman RP, Zuckerman BD, Chaitman BR, Bittl JA, Ohman EM,. Myonecrosis after revascularization procedures. J Am Coll Cardiol 1998; 31: 241-251.
2. Kini A, Marmur JD, Kini S, Dangas G, Cocke TP, Wallenstein S, Brown E, Ambrose JA, Sharma SK,. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: Implications for early discharge after coronary intervention. J Am Coll Cardiol 1999; 34: 663-671.
3. Tardiff BE, Califf RM, Tcheng JE, Lincoff AM, Sigmon KN, Harrington RA, Mahaffey KW, Ohman EM, Teirstein PS, Blankenship JC, Kitt MM, Topol EJ,. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II investigators. Integrilin (eptifibatide) to minimize platelet aggregation and coronary thrombosis-II. J Am Coll Cardiol 1999; 33: 88-96.
4. Jang JS, Hong MK, Park DW, Lee SW, Kim YH, Lee CW, Kim JJ, Park SW, Park SJ,. Impact of periprocedural myonecrosis on clinical events after implantation of drug-eluting stents. Int J Cardiol 2008; 129: 368-372.
5. Akkerhuis KM, Alexander JH, Tardiff BE, Boersma E, Harrington RA, Lincoff AM, Simoons ML,. Minor myocardial damage and prognosis: Are spontaneous and percutaneous coronary intervention-related events different? Circulation 2002; 105: 554-556.
6. Stone GW, Mehran R, Dangas G, Lansky AJ, Kornowski R, Leon MB,. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: A device-specific analysis of 7147 patients. Circulation 2001; 104: 642-647.
7. Saucedo JF, Mehran R, Dangas G, Hong MK, Lansky A, Kent KM, Satler LF, Pichard AD, Stone GW, Leon MB,. Long-term clinical events following creatine kinase-Myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol 2000; 35: 1134-1141.
8. Colombo A, Stankovic G,. Nothing is lower than 0, and 3 is closer to 0 than to 5-Medicine is not arithmetic. Eur Heart J 2002; 23: 840-842.
9. Ellis SG, Chew D, Chan A, Whitlow PL, Schneider JP, Topol EJ,. Death following creatine kinase-MB elevation after coronary intervention: Identification of an early risk period: Importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy. Circulation 2002; 106: 1205-1210.
10. Higgins JP, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
11. Egger M, Davey Smith G, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
12. Brener SJ, Lytle BW, Schneider JP, Ellis SG, Topol EJ,. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. J Am Coll Cardiol 2002; 40: 1961-1967.
13. Kini AS, Lee P, Marmur JD, Agarwal A, Duffy ME, Kim MC, Sharma SK,. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality. Am J Cardiol 2004; 93: 18-23.
14. Cavallini C, Savonitto S, Violini R, Arraiz G, Plebani M, Olivari Z, Rubartelli P, Battaglia S, Niccoli L, Steffenino G, Ardissino D, Italian 'Atherosclerosis, Thorombosis, and Vascular Biology' and 'Society for Invasive Cardiology-GISE' Investigators. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: Results of the CK-MB and PCI study. Eur Heart J 2005; 26: 1494-1498.
15. Andron M, Stables RH, Egred M, Alahmar AE, Shaw MA, Roberts E, Albouaini K, Grayson AD, Perry RA, Palmer ND,. Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention. J Invasive Cardiol 2008; 20: 108-112.
16. Lindsey JB, Kennedy KF, Stolker JM, Gilchrist IC, Mukherjee D, Marso SP, Pencina MJ, Kleiman NS, Cohen DJ,. Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: Results from the evaluation of drug-eluting stents and ischemic events (EVENT) registry. Circ Cardiovasc Interv 2011; 4: 474-480.
17. Kong TQ, Davidson CJ, Meyers SN, Tauke JT, Parker MA, Bonow RO,. Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA 1997; 277: 461-466.
18. Alpert JS, Thygesen K, Antman E, Bassand JP,. Myocardial infarction redefined-A consensus document of the joint European society of Cardiology/American college of cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969.
19. Prasad A, Herrmann J,. Myocardial infarction due to percutaneous coronary intervention. N Engl J Med 2011; 364: 453-464.
20. Ioannidis JP, Karvouni E, Katritsis DG,. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. J Am Coll Cardiol 2003; 42: 1406-1411.
21. Selvanayagam JB, Petersen SE, Francis JM, Robson MD, Kardos A, Neubauer S, Taggart DP,. Effects of off-pump versus on-pump coronary surgery on reversible and irreversible myocardial injury: A randomized trial using cardiovascular magnetic resonance imaging and biochemical markers. Circulation 2004; 109: 345-350.
22. Selvanayagam JB, Porto I, Channon K, Petersen SE, Francis JM, Neubauer S, Banning AP,. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: Insights from cardiovascular magnetic resonance imaging. Circulation 2005; 111: 1027-1032.
23. Mehran R, Dangas G, Mintz GS, Lansky AJ, Pichard AD, Satler LF, Kent KM, Stone GW, Leon MB,. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: Intravascular ultrasound study of 2256 patients. Circulation 2000; 101: 604-610.
24. Hong YJ, Mintz GS, Kim SW, Lee SY, Okabe T, Pichard AD, Satler LF, Waksman R, Kent KM, Suddath WO, Weissman NJ,. Impact of plaque composition on cardiac troponin elevation after percutaneous coronary intervention: An ultrasound analysis. JACC Cardiovasc Imaging 2009; 2: 458-468.
25. Uetani T, Amano T, Ando H, Yokoi K, Arai K, Kato M, Marui N, Nanki M, Matsubara T, Ishii H, Izawa H, Murohara T,. The correlation between lipid volume in the target lesion, measured by integrated backscatter intravascular ultrasound, and post-procedural myocardial infarction in patients with elective stent implantation. Eur Heart J 2008; 29: 1714-1720.
26. Feldman DN, Minutello RM, Bergman G, Moussa I, Wong SC,. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes. Am J Cardiol 2009; 104: 1210-1215.
27. Bertinchant JP, Polge A, Ledermann B, Genet L, Fabbro-Peray P, Raczka F, Brunet J, Poirey S, Wittenberg O, Pernel I, Nigond J,. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris. Am J Cardiol 1999; 84: 51-57.
28. Fuchs S, Kornowski R, Mehran R, Lansky AJ, Satler LF, Pichard AD, Kent KM, Clark CE, Stone GW, Leon MB,. Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions. Am J Cardiol 2000; 85: 1077-1082.
29. Cantor WJ, Newby LK, Christenson RH, Tuttle RH, Hasselblad V, Armstrong PW, Moliterno DJ, Califf RM, Topol EJ, Ohman EM, SYMPHONY and 2nd SYMPHONY Cardiac Markers Substudy Investigators. Prognostic significance of elevated troponin I after percutaneous coronary intervention. J Am Coll Cardiol 2002; 39: 1738-1744.
30. Kizer JR, Muttrej MR, Matthai WH, McConnell J, Nardone H, Sonel AF, Keane MG, Wilensky RL,. Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention. Eur Heart J 2003; 24: 1314-1322.
31. Kini A, Kini S, Marmur JD, Bertea T, Dangas G, Cocke TP, Sharma SK,. Incidence and mechanism of creatine kinase-MB enzyme elevation after coronary intervention with different devices. Catheter Cardiovasc Interv 1999; 48: 123-129.
32. Harrington RA, Lincoff AM, Califf RM, Holmes DR,Jr, Berdan LG, O'Hanesian MA, Keeler GP, Garratt KN, Ohman EM, Mark DB,. Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: Insights from the coronary angioplasty versus excisional atherectomy trial (CAVEAT). J Am Coll Cardiol 1995; 25: 1693-1699.
33. Kugelmass AD, Cohen DJ, Moscucci M, Piana RN, Senerchia C, Kuntz RE, Baim DS,. Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting. Am J Cardiol 1994; 74: 748-754.
34. Topol EJ, Yadav JS,. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000; 101: 570-580.